DOCK2 Deficiency and GATA2 Haploinsufficiency Can Underlie Critical Coronavirus Disease 2019 (COVID-19) Pneumonia
The life-threatening coronavirus disease 2019 (COVID-19) affects about 1 in 1,000 healthy people under 50 without underlying conditions. Among patients with critical COVID-19 pneumonia, rare germline variants at genes controlling type I IFN immunity have been reported in up to 5% of patients. Causal etiologies in 80-85% of cases are still unknown. We analyzed two families with hypoxemic COVID-19 pneumonia for known single-gene inborn errors of immunity. In Family 1, two siblings with critical COVID-19 were homozygous for a DOCK2 variant, c.3624+5G>A. DOCK2 deficiency is a known T-cell disorder underlying severe viral diseases. The variant resulted in skipping exon 35, which was predicted to produce a frameshift truncated protein (p.L1157Ifs*12). The proband showed markedly decreased blood CD4 T-helper cell counts, impaired T lymphocyte transformation test, and increased serum IgG, IgA, and IgE levels, as documented in other DOCK2-deficient patients. In Family 2, the proband had lethal COVID-19 and HPV-2-associated multiple recalcitrant warts. She was heterozygous for a deletion in GATA2:c.1075_1102del28, p.W360Sfs*18. GATA2 haploinsufficiency is a known cause of severe viral diseases due to a lack of plasmacytoid dendritic cell (pDC) development. The proband had monocytopenia and a lack of circulating pDCs, as reported in other patients with GATA2 haploinsufficiency. Overall, both DOCK2 deficiency and GATA2 haploinsufficiency are associated with critical and often fatal COVID-19 pneumonia.
Authors
- Vida Homayouni
- Amir Hossein Saeidian (ORCID: https://orcid.org/0000-0003-3512-0654)
- Mojtaba A Rahimi
- Mohammad Amin Tabatabaiefar (ORCID: https://orcid.org/0000-0003-1476-2877)
- Erfan Khorram (ORCID: https://orcid.org/0000-0002-3543-9131)
- Bahareh Abtahi‐Naeini (ORCID: https://orcid.org/0000-0003-1081-9477)
- Nikoo Mozafari (ORCID: https://orcid.org/0000-0003-4691-2606)
- Sharareh Babaei
- Fatemeh Vahidnezhad (ORCID: https://orcid.org/0000-0002-8111-8427)
- Lam C. Tsoi (ORCID: https://orcid.org/0000-0003-1627-5722)
- Johann Eli Gudjonsson (ORCID: https://orcid.org/0000-0002-0080-0812)
- Emmanuelle Jouanguy (ORCID: https://orcid.org/0000-0002-7358-9157)
- Hassan Vahidnezhad (ORCID: https://orcid.org/0000-0003-4298-9147)
- Shirin Zaresharifi (ORCID: https://orcid.org/0000-0003-4002-6953)
- Vivien Béziat (ORCID: https://orcid.org/0000-0002-4020-824X)
- Mohammad Shahrooei (ORCID: https://orcid.org/0000-0002-4974-3441)
- Leila Youssefian (ORCID: https://orcid.org/0000-0002-4253-6503)
- Håkon Håkonarson (ORCID: https://orcid.org/0000-0003-2814-7461)
- Fatemeh Mohaghegh (ORCID: https://orcid.org/0000-0002-8492-2410)
- Atefeh Sohanforooshan Moghaddam
- Hamid Rahimi (ORCID: https://orcid.org/0000-0002-4925-5253)
- Sajjad Biglari (ORCID: https://orcid.org/0000-0002-8206-5515)
- Qian Zhang
- Jean-Laurent Casanova (ORCID: https://orcid.org/0000-0002-7782-4169)
- Aurélie Cobat
- Roya Sherkat (ORCID: https://orcid.org/0000-0002-8574-2091)
Institutions
- Isfahan University of Medical Sciences (IR)
- Shahed University (IR)
- City Of Hope National Medical Center (US)
- Howard Hughes Medical Institute (US)
- Inserm (FR)
- University of Shahrood (IR)
- Baylor College of Medicine (US)
- Islamic Azad University North Tehran Branch (IR)
- Université Paris Cité (FR)
- University of Maryland Eastern Shore (US)
- University of Michigan (US)
- Hospital for Sick Children Pediatric Center (US)
- Institut des Maladies Génétiques Imagine (FR)
- Shahid Beheshti University of Medical Sciences (IR)
- University of Pennsylvania (US)
- Rockefeller University (US)
- UCLouvain (BE)
Publication Details
- Journal
- Journal of Clinical Immunology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1007/s10875-025-01877-z
- Citations
- 2
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.59
Funders
- LEO Fondet
- National Institutes of Health